Skip to content
healthcare.dev

Loratadine

NDC 68788-8659, Loratadine, tablet, from Preferred Pharmaceuticals Inc..

Product NDC
68788-8659
Status
Listed
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA210722
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8659 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LORATADINE10 mg/1
Package NDCNDC-11Package
68788-8659-06878886590010 TABLET in 1 BOTTLE (68788-8659-0)
68788-8659-16878886590114 TABLET in 1 BOTTLE (68788-8659-1)
68788-8659-36878886590330 TABLET in 1 BOTTLE (68788-8659-3)
68788-8659-56878886590515 TABLET in 1 BOTTLE (68788-8659-5)
68788-8659-96878886590990 TABLET in 1 BOTTLE (68788-8659-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68788-8659 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-8659 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-8659. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.